Altimmune, Inc. revenue breakdown overview

Altimmune, Inc. revenue for the last year amounted to 426.00 k USD, the most of which — 426.00 k USD — came from its highest performing source at the moment, Treatments for Various Diseases and Disorders, and Vaccines, the year earlier bringing -68.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought Altimmune, Inc. 426.00 k USD, and the year before that — -68.00 k USD.